These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17172814)

  • 1. hTERT/re-caspase-3 system induce apoptosis in hTERT-positive cancer cells.
    Yang LF; Zhao Y; Zeng L; Gong JP; Cao Y
    Cancer Biol Ther; 2006 Nov; 5(11):1546-53. PubMed ID: 17172814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter.
    Komata T; Kondo Y; Kanzawa T; Hirohata S; Koga S; Sumiyoshi H; Srinivasula SM; Barna BP; Germano IM; Takakura M; Inoue M; Alnemri ES; Shay JW; Kyo S; Kondo S
    Cancer Res; 2001 Aug; 61(15):5796-802. PubMed ID: 11479218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel telomerase-specific gene therapy: gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter.
    Koga S; Hirohata S; Kondo Y; Komata T; Takakura M; Inoue M; Kyo S; Kondo S
    Hum Gene Ther; 2000 Jul; 11(10):1397-406. PubMed ID: 10910137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase-8 gene therapy using the human telomerase reverse transcriptase promoter for malignant glioma cells.
    Komata T; Kondo Y; Kanzawa T; Ito H; Hirohata S; Koga S; Sumiyoshi H; Takakura M; Inoue M; Barna BP; Germano IM; Kyo S; Kondo S
    Hum Gene Ther; 2002 Jun; 13(9):1015-25. PubMed ID: 12067435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
    Song Y; Shen K; He CX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
    Song Y; Shen K; Yu JR
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel treatment of human malignant gliomas in vitro and in vivo: FADD gene transfer under the control of the human telomerase reverse transcriptase gene promoter.
    Komata T; Koga S; Hirohata S; Takakura M; Germano IM; Inoue M; Kyo S; Kondo S; Kondo Y
    Int J Oncol; 2001 Nov; 19(5):1015-20. PubMed ID: 11605003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma.
    Wang Y; Huang F; Cai H; Wu Y; He G; Tan WS
    J Cancer Res Clin Oncol; 2010 Dec; 136(12):1827-37. PubMed ID: 20213096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter.
    He LF; Wang YG; Xiao T; Zhang KJ; Li GC; Gu JF; Chu L; Tang WH; Tan WS; Liu XY
    Cancer Lett; 2009 Dec; 286(2):196-205. PubMed ID: 19564073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of colorectal tumor growth by regulated survivin targeting.
    Li B; Fan J; Liu X; Qi R; Bo L; Gu J; Qian C; Liu X
    J Mol Med (Berl); 2006 Dec; 84(12):1077-86. PubMed ID: 17077982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of caspase transfer using the human telomerase reverse transcriptase promoter and conventional therapies for malignant glioma cells.
    Takeuchi H; Kanzawa T; Kondo Y; Komata T; Hirohata S; Kyo S; Kondo S
    Int J Oncol; 2004 Jul; 25(1):57-63. PubMed ID: 15201989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated suicide gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter induced apoptosis of ovarian cancer cell line.
    Song JS; Kim HP; Yoon WS; Lee KW; Kim MH; Kim KT; Kim HS; Kim YT
    Biosci Biotechnol Biochem; 2003 Nov; 67(11):2344-50. PubMed ID: 14646192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FADD gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter to restrict induction of apoptosis to tumors in vitro and in vivo.
    Koga S; Hirohata S; Kondo Y; Komata T; Takakura M; Inoue M; Kyo S; Kondo S
    Anticancer Res; 2001; 21(3B):1937-43. PubMed ID: 11497281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of PUMA for malignant glioma cells regardless of p53 status.
    Ito H; Kanzawa T; Miyoshi T; Hirohata S; Kyo S; Iwamaru A; Aoki H; Kondo Y; Kondo S
    Hum Gene Ther; 2005 Jun; 16(6):685-98. PubMed ID: 15960600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase reverse transcriptase interference synergistically promotes tumor necrosis factor‑related apoptosis‑inducing ligand‑induced oral squamous cell carcinoma apoptosis and suppresses proliferation in vitro and in vivo.
    Zhao X; Zhang C; Le Z; Zeng S; Pan C; Shi J; Wang J; Zhao X
    Int J Mol Med; 2018 Sep; 42(3):1283-1294. PubMed ID: 29901096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective suppression of autocatalytic caspase-3 driven by two-step transcriptional amplified human telomerase reverse transcriptase promoter on ovarian carcinoma growth in vitro and in mice.
    Song Y; Xin X; Xia Z; Zhai X; Shen K
    Oncol Rep; 2014 Jul; 32(1):225-34. PubMed ID: 24858697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
    Majumdar AS; Hughes DE; Lichtsteiner SP; Wang Z; Lebkowski JS; Vasserot AP
    Gene Ther; 2001 Apr; 8(7):568-78. PubMed ID: 11319624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma.
    Liu L; Wu W; Zhu G; Liu L; Guan G; Li X; Jin N; Chi B
    Int J Mol Med; 2012 Oct; 30(4):747-54. PubMed ID: 22842823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase-specific replication-selective virotherapy for human cancer.
    Kawashima T; Kagawa S; Kobayashi N; Shirakiya Y; Umeoka T; Teraishi F; Taki M; Kyo S; Tanaka N; Fujiwara T
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):285-92. PubMed ID: 14734481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of telomerase activity by dominant-negative hTERT retards the growth of breast cancer cells.
    Rao Y; Xiong W; Liu H; Jia C; Zhang H; Cui Z; Zhang Y; Cui J
    Breast Cancer; 2016 Mar; 23(2):216-23. PubMed ID: 25098685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.